Accessibility Menu
 
Envoy Medical logo

Envoy Medical

(NASDAQ) COCH

Current Price$0.65
Market Cap$50.97M
Since IPO (2021)-93%
5 YearN/A
1 Year-49%
1 Month-2%

Envoy Medical Financials at a Glance

Market Cap

$50.97M

Revenue (TTM)

$241.00K

Net Income (TTM)

$23.76M

EPS (TTM)

$-1.24

P/E Ratio

-0.54

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.65

Volume

112,473

Open

$0.67

Previous Close

$0.65

Daily Range

$0.64 - $0.67

52-Week Range

$0.36 - $1.91

COCH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Envoy Medical

Industry

Healthcare Equipment and Supplies

Employees

43

CEO

Brent T. Lucas

Headquarters

White Bear Lake, MN 55110, US

COCH Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-92%

Net Income Margin

-99%

Return on Equity

0%

Return on Capital

7%

Return on Assets

-3%

Earnings Yield

-1.85%

Dividend Yield

0.00%

Payout Ratio

-7.66%

Stock Overview

Market Cap

$50.97M

Shares Outstanding

76.88M

Volume

112.47K

Short Interest

0.00%

Avg. Volume

775.52K

Financials (TTM)

Gross Profit

$633.00K

Operating Income

$22.27M

EBITDA

$21.97M

Operating Cash Flow

$18.20M

Capital Expenditure

$179.00K

Free Cash Flow

$18.38M

Cash & ST Invst.

$3.74M

Total Debt

$919.00K

Envoy Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$75.00K

+78.6%

Gross Profit

$136.00K

-18.3%

Gross Margin

-1.81%

N/A

Market Cap

$50.97M

N/A

Market Cap/Employee

$1.21M

N/A

Employees

42

N/A

Net Income

$6.59M

-42.6%

EBITDA

$6.61M

-57.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.82M

+119.9%

Accounts Receivable

$34.00K

-95.8%

Inventory

$1.55M

-9.5%

Long Term Debt

$745.00K

-96.2%

Short Term Debt

$174.00K

+21.7%

Return on Assets

-2.78%

N/A

Return on Invested Capital

7.41%

N/A

Free Cash Flow

$5.86M

-52.0%

Operating Cash Flow

$5.68M

-29.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATHAAthira Pharma, Inc.
$6.75-6.12%
ADGMAdagio Medical Holdings, Inc.
$1.41+0.00%
IRIXIRIDEX Corporation
$1.04+0.97%
VVOSVivos Therapeutics, Inc.
$1.16-3.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$183.91+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%
PLTRPalantir Technologies
$130.49-0.07%

Questions About COCH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.